Sponsored By
Randy Hubbell

Randy Hubbell

Randy Hubbell is president and CEO of Carmell Therapeutics, a clinical-stage biotechnology company focused on the development and commercialization of regenerative medicine solutions to accelerate bone and soft tissue healing. Hubbell has worked in the industry for more than 25 years, serving in leadership roles at Cardiva Medical, Johnson & Johnson, Enmed, Vasca, Boston Scientific, and IBM.

 

###


Sign up for the QMED & MD+DI Daily newsletter.